Scott Bradfield
Pediatric Hematology-Oncology · Jacksonville, FLNPI 1972514495
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 48 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 12 manufacturers, the largest accounting for just 21.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $321 and has fallen 93.7% since, to $20 in 2025.
Across 48 payments — averaging $18.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$194
- AstraZeneca$186
- Sobi, Inc$119
- Bayer$111
- Servier Pharmaceuticals LLC$89
- Jazz Pharmaceuticals Inc.$61
- plus $147 from 6 others
Across 21 payments — averaging $15,196 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- E.r. Squibb & Sons, L.L.C.$207K
- Jazz Pharmaceuticals Inc.$95K
- AbbVie$12K
- Incyte Corporation$4K
- Novartis$1K
What the payments were for
- Food & beverage$906100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $194 |
| AstraZeneca | 10 | $186 |
| Sobi, Inc | 6 | $119 |
| Bayer | 6 | $111 |
| Servier Pharmaceuticals LLC | 5 | $89 |
| Jazz Pharmaceuticals Inc. | 3 | $61 |
| Novo Nordisk | 3 | $52 |
| Seagen Inc. | 1 | $22 |
| USWM, LLC | 1 | $20 |
| Pfizer | 1 | $20 |
| RARE Disease Therapeutics, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
How this compares
$906 in reported general payments places this provider in the 55th percentile of 132 pediatric hematology-oncology providers in Florida.
See all pediatric hematology-oncology providers in Florida →
Other pediatric hematology-oncology in Jacksonville
- Howard KatzensteinJacksonville$12K
- Manisha BansalJacksonville$3K
- Darren KlawinskiJacksonville$3K
- Cynthia GaugerJacksonville$2K
- Michael JoyceJacksonville$1K
- Allison BechtelJacksonville$695
- Guillermo DeanguloMiami$929K
- Shveta GuptaOrlando$714K
- Joanna DavisMiami$411K
- Fernando Corrales-MedinaMiami$335K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.